首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1581056

罕見血液學的全球市場，2024-2028

Global Rare Hematology Market 2024-2028

出版日期: 2024年10月09日 | 出版商:

TechNavio | 英文 210 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

稀有血液學市場，2024-2028

2023-2028 年，罕見血液學市場價值估計為 45.851 億美元，預測期內複合年成長率為 5.7%。該報告包括對罕見血液學市場的總體分析、市場規模和預測、趨勢、成長促進因素、挑戰以及涵蓋約 25 家供應商的供應商分析。

它提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。該市場的促進因素包括戰略投資組合的強化、對罕見血癌基因突變的日益關注以及罕見血液疾病的流行。

市場範圍
基準年	2024年
結束年份	2028年
預測期	2024-2028
成長動力	加速度
年與前一年同期比較[2024]	5.1%
複合年成長率	5.7%
增量	45.851 億美元

該研究將食品藥物管理局(FDA) 的核准視為未來幾年推動罕見血液學市場成長的關鍵原因之一。此外，擴大採用現代化臨床試驗方法和擴大行業合作也將導致市場的強勁需求。

區域細分
比較：按地區
北美：2023-2028 年市場規模與預測
歐洲：2023-2028 年市場規模與預測
亞洲：2023-2028 年市場規模與預測
其他：2023-2028年市場規模與預測
美國：2023-2028 年市場規模與預測
中國：2023-2028年市場規模及預測
英國：2023-2028 年市場規模與預測
德國：2023-2028年市場規模與預測
日本：2023-2028年市場規模與預測
印度：2023-2028年市場規模與預測
法國：2023-2028年市場規模與預測
義大利：2023-2028年市場規模與預測
韓國：2023-2028年市場規模及預測
新加坡：2023-2028 年市場規模與預測
按區域情況分類的市場機會

第12章促進因素、挑戰、機會與限制因素

市場促進因素
市場問題
促進因素和挑戰的影響
市場機會與限制

第13章競爭格局

概述
競爭格局
混亂的情況
產業風險

第14章競爭分析

公司簡介
公司排名指數
公司市場定位
AbbVie Inc.
AstraZeneca Plc
Bayer AG
bluebird bio Inc.
Bristol Myers Squibb Co.
CSL Ltd.
F. Hoffmann La Roche Ltd.
Jazz Pharmaceuticals Plc
Johnson and Johnson Services Inc.
Merck and Co. Inc.
Novartis AG
Novo Nordisk AS
Pfizer Inc.
Sanofi SA
Takeda Pharmaceutical Co. Ltd.

第15章附錄

簡介目錄圖表

Product Code: IRTNTR80228

Rare Hematology Market 2024-2028

The rare hematology market is forecasted to grow by USD 4585.1 million during 2023-2028, accelerating at a CAGR of 5.7% during the forecast period. The report on the rare hematology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by enhancement of strategic portfolios, growing focus on genetic variants in rare blood cancers, and prevalence of rare hematologic disorders.

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	5.1%
CAGR	5.7%
Incremental Value	$4585.1 mn

Technavio's rare hematology market is segmented as below:

By Disease Type

Hemophilia
Sickle cell disease
Thalassemia
Myelodysplastic syndromes

By End-user

Hospitals
Specialty clinics
Research institutes
Pharmaceutical companies

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the approvals from food and drug administration (FDA) as one of the prime reasons driving the rare hematology market growth during the next few years. Also, increasing adoption of modernized clinical trial methods and expansion of industry collaborations will lead to sizable demand in the market.

The report on the rare hematology market covers the following areas:

Rare Hematology Market sizing
Rare Hematology Market forecast
Rare Hematology Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading rare hematology market vendors that include AbbVie Inc., AstraZeneca Plc, Bayer AG, Biogen Inc., bluebird bio Inc., Bristol Myers Squibb Co., CSL Ltd., Emmaus Medical Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Grifols SA, Jazz Pharmaceuticals Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Novo Nordisk AS, Octapharma AG, Pfizer Inc., Sanofi SA, and Takeda Pharmaceutical Co. Ltd.. Also, the rare hematology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Disease Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value Chain Analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2023
4.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

5.1 Global Rare Hematology Market 2018 - 2022
- Historic Market Size - Data Table on Global Rare Hematology Market 2018 - 2022 ($ million)
5.2 Disease Type segment analysis 2018 - 2022
- Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
5.3 End-user segment analysis 2018 - 2022
- Historic Market Size - End-user Segment 2018 - 2022 ($ million)
5.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
5.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

6 Qualitative Analysis

6.1 Impact of Artificial Intelligence (AI) in the global rare hematology market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
7.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

8 Market Segmentation by Disease Type

8.1 Market segments
- Chart on Disease Type - Market share 2023-2028 (%)
- Data Table on Disease Type - Market share 2023-2028 (%)
8.2 Comparison by Disease Type
- Chart on Comparison by Disease Type
- Data Table on Comparison by Disease Type
8.3 Hemophilia - Market size and forecast 2023-2028
- Chart on Hemophilia - Market size and forecast 2023-2028 ($ million)
- Data Table on Hemophilia - Market size and forecast 2023-2028 ($ million)
- Chart on Hemophilia - Year-over-year growth 2023-2028 (%)
- Data Table on Hemophilia - Year-over-year growth 2023-2028 (%)
8.4 Sickle cell disease - Market size and forecast 2023-2028
- Chart on Sickle cell disease - Market size and forecast 2023-2028 ($ million)
- Data Table on Sickle cell disease - Market size and forecast 2023-2028 ($ million)
- Chart on Sickle cell disease - Year-over-year growth 2023-2028 (%)
- Data Table on Sickle cell disease - Year-over-year growth 2023-2028 (%)
8.5 Thalassemia - Market size and forecast 2023-2028
- Chart on Thalassemia - Market size and forecast 2023-2028 ($ million)
- Data Table on Thalassemia - Market size and forecast 2023-2028 ($ million)
- Chart on Thalassemia - Year-over-year growth 2023-2028 (%)
- Data Table on Thalassemia - Year-over-year growth 2023-2028 (%)
8.6 Myelodysplastic syndromes - Market size and forecast 2023-2028
- Chart on Myelodysplastic syndromes - Market size and forecast 2023-2028 ($ million)
- Data Table on Myelodysplastic syndromes - Market size and forecast 2023-2028 ($ million)
- Chart on Myelodysplastic syndromes - Year-over-year growth 2023-2028 (%)
- Data Table on Myelodysplastic syndromes - Year-over-year growth 2023-2028 (%)
8.7 Market opportunity by Disease Type
- Market opportunity by Disease Type ($ million)
- Data Table on Market opportunity by Disease Type ($ million)

9 Market Segmentation by End-user

9.1 Market segments
- Chart on End-user - Market share 2023-2028 (%)
- Data Table on End-user - Market share 2023-2028 (%)
9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
9.3 Hospitals - Market size and forecast 2023-2028
- Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
- Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
- Chart on Hospitals - Year-over-year growth 2023-2028 (%)
- Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
9.4 Specialty clinics - Market size and forecast 2023-2028
- Chart on Specialty clinics - Market size and forecast 2023-2028 ($ million)
- Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ million)
- Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
- Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)
9.5 Research institutes - Market size and forecast 2023-2028
- Chart on Research institutes - Market size and forecast 2023-2028 ($ million)
- Data Table on Research institutes - Market size and forecast 2023-2028 ($ million)
- Chart on Research institutes - Year-over-year growth 2023-2028 (%)
- Data Table on Research institutes - Year-over-year growth 2023-2028 (%)
9.6 Pharmaceutical companies - Market size and forecast 2023-2028
- Chart on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
- Data Table on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
- Chart on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
- Data Table on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
9.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

10 Customer Landscape

10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

11.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
11.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
11.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
11.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
11.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
11.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
11.8 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
11.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
11.10 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
11.11 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
11.12 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)
11.13 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
11.14 Italy - Market size and forecast 2023-2028
- Chart on Italy - Market size and forecast 2023-2028 ($ million)
- Data Table on Italy - Market size and forecast 2023-2028 ($ million)
- Chart on Italy - Year-over-year growth 2023-2028 (%)
- Data Table on Italy - Year-over-year growth 2023-2028 (%)
11.15 South Korea - Market size and forecast 2023-2028
- Chart on South Korea - Market size and forecast 2023-2028 ($ million)
- Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
- Chart on South Korea - Year-over-year growth 2023-2028 (%)
- Data Table on South Korea - Year-over-year growth 2023-2028 (%)
11.16 Singapore - Market size and forecast 2023-2028
- Chart on Singapore - Market size and forecast 2023-2028 ($ million)
- Data Table on Singapore - Market size and forecast 2023-2028 ($ million)
- Chart on Singapore - Year-over-year growth 2023-2028 (%)
- Data Table on Singapore - Year-over-year growth 2023-2028 (%)
11.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
12.4 Market opportunities/restraints

13 Competitive Landscape

13.1 Overview
13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
- Overview on factors of disruption
13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered
14.2 Company ranking index
- Company ranking index
14.3 Market positioning of companies
- Matrix on companies position and classification
14.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
14.5 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
14.6 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
14.7 bluebird bio Inc.
- bluebird bio Inc. - Overview
- bluebird bio Inc. - Product / Service
- bluebird bio Inc. - Key offerings
- SWOT
14.8 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
14.9 CSL Ltd.
- CSL Ltd. - Overview
- CSL Ltd. - Business segments
- CSL Ltd. - Key news
- CSL Ltd. - Key offerings
- CSL Ltd. - Segment focus
- SWOT
14.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
14.11 Jazz Pharmaceuticals Plc
- Jazz Pharmaceuticals Plc - Overview
- Jazz Pharmaceuticals Plc - Product / Service
- Jazz Pharmaceuticals Plc - Key news
- Jazz Pharmaceuticals Plc - Key offerings
- SWOT
14.12 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT
14.13 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
14.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
14.15 Novo Nordisk AS
- Novo Nordisk AS - Overview
- Novo Nordisk AS - Business segments
- Novo Nordisk AS - Key offerings
- Novo Nordisk AS - Segment focus
- SWOT
14.16 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
14.17 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
14.18 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- SWOT

15 Appendix

15.1 Scope of the report
15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
15.3 Currency conversion rates for US$
- Currency conversion rates for US$
15.4 Research methodology
- Research methodology
15.5 Data procurement
- Information sources
15.6 Data validation
- Data validation
15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
15.8 Data synthesis
- Data synthesis
15.9 360 degree market analysis
- 360 degree market analysis
15.10 List of abbreviations
- List of abbreviations

簡介目錄圖表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits11: Overview on criticality of inputs and factors of differentiation
Exhibits12: Overview on factors of disruption
Exhibits13: Impact of drivers and challenges in 2023 and 2028
Exhibits14: Parent Market
Exhibits15: Data Table on - Parent Market
Exhibits16: Market characteristics analysis
Exhibits17: Value Chain Analysis
Exhibits18: Offerings of companies included in the market definition
Exhibits19: Market segments
Exhibits20: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits21: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits22: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits23: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits24: Historic Market Size - Data Table on Global Rare Hematology Market 2018 - 2022 ($ million)
Exhibits25: Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
Exhibits26: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits27: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits28: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits29: Five forces analysis - Comparison between 2023 and 2028
Exhibits30: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits31: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits32: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits33: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits34: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits35: Chart on Market condition - Five forces 2023 and 2028
Exhibits36: Chart on Disease Type - Market share 2023-2028 (%)
Exhibits37: Data Table on Disease Type - Market share 2023-2028 (%)
Exhibits38: Chart on Comparison by Disease Type
Exhibits39: Data Table on Comparison by Disease Type
Exhibits40: Chart on Hemophilia - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Hemophilia - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Hemophilia - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Hemophilia - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Sickle cell disease - Market size and forecast 2023-2028 ($ million)
Exhibits45: Data Table on Sickle cell disease - Market size and forecast 2023-2028 ($ million)
Exhibits46: Chart on Sickle cell disease - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Sickle cell disease - Year-over-year growth 2023-2028 (%)
Exhibits48: Chart on Thalassemia - Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Thalassemia - Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Thalassemia - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Thalassemia - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Myelodysplastic syndromes - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Myelodysplastic syndromes - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Myelodysplastic syndromes - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Myelodysplastic syndromes - Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Disease Type ($ million)
Exhibits57: Data Table on Market opportunity by Disease Type ($ million)
Exhibits58: Chart on End-user - Market share 2023-2028 (%)
Exhibits59: Data Table on End-user - Market share 2023-2028 (%)
Exhibits60: Chart on Comparison by End-user
Exhibits61: Data Table on Comparison by End-user
Exhibits62: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits63: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits64: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits66: Chart on Specialty clinics - Market size and forecast 2023-2028 ($ million)
Exhibits67: Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ million)
Exhibits68: Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
Exhibits69: Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)
Exhibits70: Chart on Research institutes - Market size and forecast 2023-2028 ($ million)
Exhibits71: Data Table on Research institutes - Market size and forecast 2023-2028 ($ million)
Exhibits72: Chart on Research institutes - Year-over-year growth 2023-2028 (%)
Exhibits73: Data Table on Research institutes - Year-over-year growth 2023-2028 (%)
Exhibits74: Chart on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibits75: Data Table on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibits76: Chart on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits77: Data Table on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits78: Market opportunity by End-user ($ million)
Exhibits79: Data Table on Market opportunity by End-user ($ million)
Exhibits80: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits81: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits82: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits83: Chart on Geographic comparison
Exhibits84: Data Table on Geographic comparison
Exhibits85: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits109: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits110: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits111: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits112: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits113: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits114: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits115: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits116: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits117: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits118: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits119: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits120: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits121: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits122: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits123: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits124: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits125: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits126: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits127: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits128: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits129: Chart on Italy - Market size and forecast 2023-2028 ($ million)
Exhibits130: Data Table on Italy - Market size and forecast 2023-2028 ($ million)
Exhibits131: Chart on Italy - Year-over-year growth 2023-2028 (%)
Exhibits132: Data Table on Italy - Year-over-year growth 2023-2028 (%)
Exhibits133: Chart on South Korea - Market size and forecast 2023-2028 ($ million)
Exhibits134: Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
Exhibits135: Chart on South Korea - Year-over-year growth 2023-2028 (%)
Exhibits136: Data Table on South Korea - Year-over-year growth 2023-2028 (%)
Exhibits137: Chart on Singapore - Market size and forecast 2023-2028 ($ million)
Exhibits138: Data Table on Singapore - Market size and forecast 2023-2028 ($ million)
Exhibits139: Chart on Singapore - Year-over-year growth 2023-2028 (%)
Exhibits140: Data Table on Singapore - Year-over-year growth 2023-2028 (%)
Exhibits141: Market opportunity By Geographical Landscape ($ million)
Exhibits142: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits143: Impact of drivers and challenges in 2023 and 2028
Exhibits144: Overview on criticality of inputs and factors of differentiation
Exhibits145: Overview on factors of disruption
Exhibits146: Impact of key risks on business
Exhibits147: Companies covered
Exhibits148: Company ranking index
Exhibits149: Matrix on companies position and classification
Exhibits150: AbbVie Inc. - Overview
Exhibits151: AbbVie Inc. - Product / Service
Exhibits152: AbbVie Inc. - Key news
Exhibits153: AbbVie Inc. - Key offerings
Exhibits154: SWOT
Exhibits155: AstraZeneca Plc - Overview
Exhibits156: AstraZeneca Plc - Product / Service
Exhibits157: AstraZeneca Plc - Key news
Exhibits158: AstraZeneca Plc - Key offerings
Exhibits159: SWOT
Exhibits160: Bayer AG - Overview
Exhibits161: Bayer AG - Business segments
Exhibits162: Bayer AG - Key news
Exhibits163: Bayer AG - Key offerings
Exhibits164: Bayer AG - Segment focus
Exhibits165: SWOT
Exhibits166: bluebird bio Inc. - Overview
Exhibits167: bluebird bio Inc. - Product / Service
Exhibits168: bluebird bio Inc. - Key offerings
Exhibits169: SWOT
Exhibits170: Bristol Myers Squibb Co. - Overview
Exhibits171: Bristol Myers Squibb Co. - Product / Service
Exhibits172: Bristol Myers Squibb Co. - Key news
Exhibits173: Bristol Myers Squibb Co. - Key offerings
Exhibits174: SWOT
Exhibits175: CSL Ltd. - Overview
Exhibits176: CSL Ltd. - Business segments
Exhibits177: CSL Ltd. - Key news
Exhibits178: CSL Ltd. - Key offerings
Exhibits179: CSL Ltd. - Segment focus
Exhibits180: SWOT
Exhibits181: F. Hoffmann La Roche Ltd. - Overview
Exhibits182: F. Hoffmann La Roche Ltd. - Business segments
Exhibits183: F. Hoffmann La Roche Ltd. - Key news
Exhibits184: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits185: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits186: SWOT
Exhibits187: Jazz Pharmaceuticals Plc - Overview
Exhibits188: Jazz Pharmaceuticals Plc - Product / Service
Exhibits189: Jazz Pharmaceuticals Plc - Key news
Exhibits190: Jazz Pharmaceuticals Plc - Key offerings
Exhibits191: SWOT
Exhibits192: Johnson and Johnson Services Inc. - Overview
Exhibits193: Johnson and Johnson Services Inc. - Business segments
Exhibits194: Johnson and Johnson Services Inc. - Key news
Exhibits195: Johnson and Johnson Services Inc. - Key offerings
Exhibits196: Johnson and Johnson Services Inc. - Segment focus
Exhibits197: SWOT
Exhibits198: Merck and Co. Inc. - Overview
Exhibits199: Merck and Co. Inc. - Business segments
Exhibits200: Merck and Co. Inc. - Key news
Exhibits201: Merck and Co. Inc. - Key offerings
Exhibits202: Merck and Co. Inc. - Segment focus
Exhibits203: SWOT
Exhibits204: Novartis AG - Overview
Exhibits205: Novartis AG - Business segments
Exhibits206: Novartis AG - Key news
Exhibits207: Novartis AG - Key offerings
Exhibits208: Novartis AG - Segment focus
Exhibits209: SWOT
Exhibits210: Novo Nordisk AS - Overview
Exhibits211: Novo Nordisk AS - Business segments
Exhibits212: Novo Nordisk AS - Key offerings
Exhibits213: Novo Nordisk AS - Segment focus
Exhibits214: SWOT
Exhibits215: Pfizer Inc. - Overview
Exhibits216: Pfizer Inc. - Product / Service
Exhibits217: Pfizer Inc. - Key news
Exhibits218: Pfizer Inc. - Key offerings
Exhibits219: SWOT
Exhibits220: Sanofi SA - Overview
Exhibits221: Sanofi SA - Business segments
Exhibits222: Sanofi SA - Key news
Exhibits223: Sanofi SA - Key offerings
Exhibits224: Sanofi SA - Segment focus
Exhibits225: SWOT
Exhibits226: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits227: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits228: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits229: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits230: SWOT
Exhibits231: Inclusions checklist
Exhibits232: Exclusions checklist
Exhibits233: Currency conversion rates for US$
Exhibits234: Research methodology
Exhibits235: Information sources
Exhibits236: Data validation
Exhibits237: Validation techniques employed for market sizing
Exhibits238: Data synthesis
Exhibits239: 360 degree market analysis
Exhibits240: List of abbreviations